Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/1996
12/12/1996CA2222331A1 Heterocyclic methyl free radicals as image enhancing agents
12/12/1996CA2220756A1 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
12/12/1996CA2219528A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound
12/11/1996EP0747344A1 Process for the purification and crystallisation of iopamidol
12/11/1996EP0746339A1 X-ray contrast compositions containing cellulose derivatives
12/11/1996CN1137759A Cascade polymers with iodine aromatic compounds
12/11/1996CN1137758A Methods of prolonged suppression of humoral immunity
12/10/1996US5583278 Genetic engineered drug testing animal
12/10/1996US5583220 Pyrole nitrogen-substituted texaphyrins
12/10/1996US5583206 Chelating polymers
12/10/1996US5583008 Rapid diagnostic procedure for ivermectin resistance
12/10/1996US5582814 Complex of paramagnetic metal and 1-/para-butylbenzyl/diethylenetriaminepentaacetic acid
12/10/1996US5582813 Iodine-containing fluorocarbon contrast agents
12/10/1996US5582172 Intravascular administering a particle carrier comprising an organic inner core surface grafted with carbohydrates specific bonding to lymph nodes
12/05/1996WO1996038585A1 Reagent for measuring blood coagulation activity
12/05/1996WO1996038461A1 Cleavage of rna using metal complexes
12/05/1996WO1996038184A2 Magnetic resonance imaging agents for the detection of physiological agents
12/05/1996WO1996038183A1 Contrast medium and its use
12/05/1996WO1996038182A1 Insulin suppression test with igf
12/05/1996WO1996038181A1 Sonicated dextrose-albumin ultrasound contrast agent, containing perfluorobutane
12/05/1996WO1996038180A1 Ultrasound contrast agents, containing perfluorocarbon in dextrose-albumin microbubbles
12/05/1996WO1996038179A1 Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome
12/05/1996CA2222429A1 Contrast medium and its use
12/05/1996CA2222215A1 Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome
12/05/1996CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex
12/04/1996EP0745085A1 Texaphyrin metal complexes having improved functionalization
12/04/1996EP0744962A1 Method of storage of ultrasonic gas suspensions
12/04/1996EP0744961A1 Gas-containing microparticles, agents containing them, their use in medical diagnosis by ultrasonic techniques and methods of producing said particles and agents
12/04/1996EP0744960A1 Improvements in or relating to contrast agents
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/03/1996US5580579 Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
12/03/1996US5580575 Therapeutic drug delivery systems
12/03/1996US5580568 Tantalum, tantalum oxide and barium sulfate used as contrast agent, dimethyl sulfoxide used as biocompatible solvent; injecting embolizing agent into blood vessel
12/03/1996US5580543 Texaphyrins as radiation sensitizers
12/03/1996US5580542 Method of testing for nephritis
12/03/1996US5579769 Gel containing a 1,3-glucan
12/03/1996US5579767 Method for imaging abdominal aorta and aortic aneurysms
11/1996
11/28/1996WO1996037780A1 Compositions and methods for detecting schizophrenia
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996WO1996037238A1 3,5-bis[alkanoyl amino]-2,4,6-triiodobenzyl esters
11/28/1996WO1996037237A1 An in vivo and in vitro model of cutaneous photoaging
11/28/1996WO1996037236A1 Diagnostic imaging x-ray contrast agents
11/28/1996DE19535428A1 Radiographic barium sulphate diagnostic suspensions for imaging gastrointestinal tract
11/28/1996CA2219976A1 An in vivo and in vitro model of cutaneous photoaging
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743860A1 Preparation of hollow microcapsules
11/27/1996EP0743859A1 Chimeric oligonucleoside compounds
11/27/1996EP0711180A4 Functionalized tripodal ligands for imaging applications
11/27/1996EP0646021B1 Purification of crude ioversol using continuous deionization
11/27/1996CN1136805A Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purpose and complexs
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578325 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
11/26/1996US5578292 Contrast agent
11/26/1996US5578291 Method and composition for optimizing left ventricular videointensity in echocardiography
11/26/1996US5578288 Metal-binding targeted polypeptide constructs
11/21/1996WO1996036370A1 Process for the depyrogenation of injectable pharmaceutical solutions
11/21/1996WO1996036367A1 Composition and method for tumor imaging
11/21/1996WO1996036272A1 Controlled application of select ophthalmic agents and controlled disinfecting of multiple use articles
11/21/1996DE19514515A1 Magnetisable iron oxide nano-particle dispersion with high saturation polarisation
11/20/1996EP0742831A1 Transgenic non-human mammals with progressive neurologic disease
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742724A1 Agent for marking bodily tissues
11/20/1996EP0742721A1 Methods of prolonged suppression of humoral immunity
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136313A Polyazacycloalkanes as dichelants
11/20/1996CN1136285A Polymeric surfactant-encapsulated microbubbles and their use in ultrasound imageing
11/20/1996CN1136273A Liposomes with enhanced entrapment capacity, method and use
11/19/1996US5576295 Agent for suppressing the motor activity of gastrointestinal tracts
11/19/1996US5576290 Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction
11/19/1996US5576178 Medical diagnosis of genetic disorders from dna
11/19/1996US5575986 Chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035457A1 Suspended ultra-sound induced microbubble cavitation imaging
11/14/1996WO1996035456A2 Use of polymeric contrast agents of medium molecular weight for differentiating between benign and malignant tumours using modern imaging techniques
11/14/1996WO1996035429A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/14/1996WO1996032134A3 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/14/1996DE19518222A1 Verwendung von polymeren Kontrastmittel mittleren Molekulargewichts zur Differenzierung von benignen und malignen Tumoren mittels moderner bildgebender Verfahren Use of polymeric contrast agent-average molecular weight for the differentiation of benign and malignant tumors using modern imaging methods
11/14/1996DE19518221A1 Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen Use of non-steroidal anti-inflammatory drugs to improve the physiological tolerance particulate pharmaceutical preparations
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220052A1 Use of nonsteroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741741A1 Modified oligonucleotides
11/13/1996EP0741581A1 Oral magnetic particle formulation
11/13/1996CN1135749A Iodinated derivatives, preparation and use thereof as contrast agents in x-ray radiology
11/13/1996CN1135712A Ultrasonic spectral contrast imaging
11/12/1996US5574097 Chemical compounds
11/12/1996US5573752 Aromatic amide compounds and metal chelates thereof
11/12/1996US5573751 Fluorocarbons
11/12/1996US5573750 Diagnostic imaging x-ray contrast agents
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/07/1996WO1996034853A1 Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
11/07/1996DE19516323A1 Prodn. of magnetisable aq. dispersions
11/07/1996CA2219880A1 Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
11/06/1996EP0740559A1 A container for diagnostic contrast compositions
11/06/1996EP0740528A1 Gas microspheres for topical and subcutaneous application
11/05/1996US5571941 Dissolving crude solid in secondary butanol, crystallization
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 354